Paper
9a): white amorphous solid, 0.558 g, 100%; t
Dalton Transactions
(
R
: 15.0 min. (3H, m, CvO–NH–CHH), 3.54 (3H, d, J 15.5 Hz, CvO–CHH–
+
ES-MS m/z; HRMS (MALDI-FTICR) m/z; [M + H] calcd for N), 3.27–3.20 (9H, overlapping m, CvO–NH–CHH and N–CH2–
+
C
75
H
(
75
N
6
O
13 1267.5387; found 1267.5375.
CH
2
–CH
2
–CH
2
–NH), 1.47 (6H, m, N–CH
2
–CH
2
–CH
–NH). C NMR (150 MHz,
ES-MS m/z; HRMS (MALDI-FTICR) m/z; [M + H] calcd for CDCl ) δ: 167.2 ×3 (CvO–N), 165.3 ×3 (CvO–NH), 151.7 ×3 (m-
2 2
–CH –NH),
1
3
9b): white amorphous solid, 0.578 g, 97%; t
R
: 20.0 min. 1.27 (6H, m, N–CH –CH –CH –CH
2 2 2 2
+
3
+
C
81
H
87
N
6
O
13 1351.6326; found 1351.6390.
2
C–OBn), 146.8 ×3 (o-C–OBn), 136.4 ×6 (O–CH –C), 128.7 ×3 (C–
(
9c): white amorphous solid, 0.531 g, 84%; t
R
: 19.3 min. Ph), 128.2 ×12 (C–Ph), 127.7 ×3 (C–Ph), 127.2 ×12 (C–Ph), 124.4
+
ES-MS m/z; HRMS (MALDI-FTICR) m/z; [M + H] calcd for ×3 (m-C–Ar), 123.2 ×3 (o-C–Ar), 117.0 ×3 (p-C–Ar), 76.4 ×3 (O–
+
C
87
H
99
N
6
O
13 1435.7265; found 1435.7241.
Cyclization procedure: synthesis of the cyclic peptoids 10a– (CvO–NH–CH
c. The solutions of the linear peptoids (0.300 mmol), pre- CH –CH –NH), 23.8 ×3 (N–CH –CH –CH –CH –NH).
CH
2
–Ph), 71.3 ×3 (O–CH
2
–Ph), 48.9 ×3 (CvO–CH
2
–N), 46.5 ×3
2
), 38.9 ×3 (CvO–N–CH
2
), 26.6 ×3 (N–CH
2
–CH –
2
2
2
2
2
2
2
viously co-evaporated three times with toluene, were prepared
under nitrogen in dry DMF (15.0 mL). The mixture was added HRMS (MALDI-FTICR) m/z; [M + H] calcd for C87
dropwise to a stirred solution of HATU (0.456 g, 1.20 mmol) 1417.7159; found 1417.7185. H NMR (600 MHz, CDCl ) δ:
R
(10c): white amorphous solid, 0.0510 g, 12%; t : 22.1 min.
+
+
97 6 12
H N O
1
3
and DIPEA (324 μL, 1.86 mmol) in dry DMF (85.0 mL) by using 7.90 (3H, br t, NH), 7.72 (3H, dd, J 5.4, 4.2 Hz, o-Ar–H),
2
a syringe pump in 6 h, at room temperature in an anhydrous 7.47–7.46 (6H, overlapping, o-CH –Ph–H), 7.41–7.33 (21H, over-
atmosphere. After 12 h the resulting mixture was concentrated lapping, m-Ar–H and m-CH –Ph–H), 7.14–7.13 (9H, overlapping
2
in vacuo, diluted with CH
with a solution of HCl (1.00 M, 30.0 mL). The organic phase (6H, s, CH
was washed with water (60.0 mL), dried over anhydrous (3H, m, CvO–NH–CHH), 3.56 (3H, d, J 15.3 Hz, CvO–CHH–
2
Cl
2
2 2
(60.0 mL), and washed twice signals, p-Ar–H and p-CH –Ph–H), 5.15 (6H, s, CH –Ph), 5.07
2
–Ph), 4.66 (3H, d, J 15.3 Hz, CvO–CHH–N), 3.80
MgSO
4
, filtered and concentrated in vacuo. The crude cyclic N), 3.26–3.19 (9H, overlapping m, CvO–NH–CHH and N–CH
–(CH –CH –CH –NH), 1.47 (6H, m, N–CH –CH –(CH
2
2
–
–
peptoids were purified using flash silica gel; conditions: 1 : 1 CH
2
2
)
2
2
2
2
2
2
)
petroleum ether : ethyl acetate, then 100% ethyl acetate, and, CH –CH –NH), 1.33–1.20 (18H, overlapping m, N–CH –CH –
2
2
2
2
1
3
finally, 90 : 10 ethyl acetate : methanol. The cyclic peptoids (CH
2
)
2
2 2 3
–CH –CH –NH). C NMR (150 MHz, CDCl ) δ: 167.0 ×3
were dissolved in 50% acetonitrile in HPLC grade water and (CvO–N), 165.0 ×3 (CvO–NH), 151.7 ×3 (m-C–OBn), 146.8 ×3
analysed by RP-HPLC; purity >90% conditions: 5%–100% A in (o-C–OBn), 136.5 ×6 (O–CH –C), 128.7 ×15 (C–Ph), 127.7 ×3 (C–
2
3
0 min (A, 0.1% TFA in acetonitrile, B, 0.1% TFA in water); Ph), 127.2 ×12 (C–Ph), 124.4 ×3 (m-C–Ar), 123.4 ×3 (o-C–Ar),
−
1
1
2 2
flow: 1 mL min , 220 nm, subsequently characterized via H- 117.0 ×3 (p-C–Ar), 76.4 ×3 (O–CH –Ph), 71.4 ×3 (O–CH –Ph),
and C-NMR spectroscopy and HRMS (MALDI-FTICR).
1
3
49.0 ×3 (CvO–CH –N), 47.1 ×3 (CvO–NH–CH ), 39.4 ×3
2
2
(
10a): white amorphous solid, 0.0900 g, 24%; t : 20.2 min. (CvO–N–CH
R
2
), 29.1 ×3 (N–CH
2
–CH
–CH
2
–(CH
2
)
2
–CH
2
–CH
2
–NH),
+
HRMS (MALDI-FTICR) m/z; ([M
+
H] 49) calcd for 26.6 ×3 (N–CH
2
–CH
2
–(CH
2
)
2
–CH
2
2 2
–NH), 26.4 ×3 (N–CH –
+
+
C H N O
1249.5281; found 1249.5296; ([M + Na] 51) CH –(CH ) –CH –CH –NH), 26.3 ×3 (N–CH –CH –(CH ) –
7
5
73
6
12
2
2 2
2
2
2
2
2 2
+
1
calcd for C75
H
72
N
6
NaO12 1271.5100; found 1249.5113.
) δ: 7.85 (3H, br t, NH), 7.60 (3H, dd, J
.5, 2.9 Hz, o-Ar–H), 7.46–7.45 (6H, overlapping, o-CH –Ph–H), a solution of cyclic peptoids 10a–c (0.0300 mmol), in ethyl
H
CH
2
–CH
2
–NH).
NMR (600 MHz, CDCl
3
Hydrogenation procedure: synthesis of the ligands 3a–c. To
6
7
7
5
2
.40–7.30 (21H, overlapping, m-Ar–H and m-CH
.11–7.10 (9H, overlapping signals, p-Ar–H and p-CH
.13 (6H, s, CH –Ph), 5.07 (6H, s, CH –Ph), 4.17 (3H, d, J 15.6 cycles of vacuum-hydrogen were performed, and the reaction
2
2
–Ph–H), acetate (0.430 mL), Pd 10% wt on carbon was added (half of
–Ph–H), the weight with respect to the cyclic peptoid substrate). Three
2
2
Hz, CvO–CHH–N), 3.88 (3H, m, CvO–NH–CHH), 3.62 (3H, m, was stirred for 5 hours. After 5 hours, 0.860 mL of ethanol was
CvO–NH–CHH), 3.47 (3H, d, J 15.6 Hz, CvO–CHH–N), added, and three more vacuum-hydrogen cycles were per-
13
3
.27–3.23 (6H, overlapping m, N–CH –CH –NH). C NMR formed. The reaction mixture was stirred for an additional
2 2
(
150 MHz, CDCl
3
) δ: 167.7 ×3 (CvO–N), 165.8 ×3 (CvO–NH), 19 hours, then the completion of the reaction was assessed via
1
1
×
51.8 ×3 (m-C–OBn), 146.7 ×3 (o-C–OBn), 136.6 ×3 (O–CH –C), TLC. The reaction mixture was filtered with ethanol using a
2
36.4 ×3 (O–CH –C), 128.9 ×3 (C–Ph), 128.6 ×12 (C–Ph), 128.2 Celite pad and extensively dried in vacuo to obtain the final
2
3 (C–Ph), 127.6 ×12 (C–Ph), 124.3 ×3 (m-C–Ar), 122.8 ×3 (o-C– products. The cyclic peptoids were dissolved in 50% aceto-
Ar), 116.9 ×3 (p-C–Ar), 76.2 ×3 (O–CH
2
–Ph), 71.2 ×3 (O–CH
2
–
nitrile in HPLC grade water and analysed by RP-HPLC; purity
Ph), 48.7 ×3 (CvO–CH –N), 46.1 ×3 (CvO–NH–CH ), 36.7 ×3 >90% conditions: 5%–100% A in 30 min (A, 0.1% TFA in aceto-
2
2
−
1
(
CvO–N–CH
(
2
).
nitrile, B, 0.1% TFA in water); flow: 1 mL min , 220 nm, sub-
1
13
10b): white amorphous solid, 0.0960 g, 24%; t : 18.4 min. sequently characterized via H- and C-NMR spectroscopy and
HRMS (MALDI-FTICR) m/z; [M + H] calcd for C H N O
333.6220; found 1333.6246. H NMR (600 MHz, CDCl
.99 (3H, br t, NH), 7.69 (3H, dd, J 7.6, 1.8 Hz, o-Ar–H), HRMS (MALDI-FTICR) m/z; [M
R
+
+
HRMS (MALDI-FTICR).
8
1
85
6
12
1
1
7
7
3
) δ:
(3a): white amorphous solid, 0.0210 g, 100%; t
R
: 9.9 min.
calcd for
+
+
Na]
+
1
.46–7.45 (6H, overlapping, o-CH –Ph–H) 7.40–7.33 (21H, over- C H N NaO
12
731.2283; found 731.2293.
OD) δ: 7.12 (3H, dd, J 8.2, 1.1 Hz, o-Ar–H), 6.90
–Ph), 5.08 (3H, dd, J 8.2, 1.1 Hz, m-Ar–H), 6.68 (3H, t, J 8.1 Hz, p-Ar–H),
6H, s, CH –Ph), 4.63 (3H, d, J 15.5 Hz, CvO–CHH–N), 3.76 5.13 (3H, d, J 15.8 Hz, CvO–CHH–N), 3.86 (3H, m, CvO–NH–
H
NMR
2
33 36
6
lapping, m-Ar–H and m-CH
2
–Ph–H), 7.13–7.08 (9H, overlapping (600 MHz, CD
–Ph–H), 5.14 (6H, s, CH
3
signals, p-Ar–H and p-CH
2
2
(
2
Dalton Trans.
This journal is © The Royal Society of Chemistry 2020